NCT00541320撤回2 期
Dose Ranging Trial for the Evaluation of the Safety and Efficacy of GW813893 in the Prophylaxis of Venous Thromboembolism Post Total Knee Replacement Surgery.
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 撤回
- 试验地点
- 10
- 主要终点
- Incidence of death OR symptomatic or non-symptomatic blood clots in the legs OR symptomatic blood clots in the lungs within 7 +/- 2 days following total knee replacement surgery.
研究概览
简要总结
This study was designed to assess the safety and efficacy of GW813893 in the prophylaxis of VTE following TKR and to provide evidence to enable the selection of the appropriate dose(s) and dose regimen of GW813893 for future investigation.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 85 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Incidence of death OR symptomatic or non-symptomatic blood clots in the legs OR symptomatic blood clots in the lungs within 7 +/- 2 days following total knee replacement surgery.
时间窗: symptomatic blood clots in the lungs within 7 +/- 2 days following total knee replacement surgery.
次要结局
- Incidence of bleeding within 7 +/- 2 days following total knee replacement surgery.(Incidence of bleeding within 7 +/- 2 days following total knee replacement surgery)
研究者
研究点 (10)
Loading locations...
相似试验
已完成
1 期
Three-Dose Regimen of MRKAd5+6 Trigene (V526) in Healthy Adults (V526-001)(COMPLETED)HIVHIV InfectionsNCT00850616Merck Sharp & Dohme LLC147
撤回
3 期
Phase 3, 28-week, Randomized, Double-blind, Placebo-controlled Safety and Efficacy Study of Nabiximols as an add-on Therapy in Subjects With Spasticity Due to Multiple Sclerosis.SpasticityMultiple SclerosisNCT01868048GW Research Ltd
进行中（未招募）
不适用
Assessment of Efficacy and Safety of Olmesartan Medoxomil in Children and Adolescent Patients With High Blood PressureHypertensionEUCTR2015-003329-32-Outside-EU/EEADaiichi Sankyo Pharma Development362
已完成
3 期
Long Term Effectiveness and Safety Study for RWJ-333369 as Adjunctive Therapy in Korean and Japanese Patients With Partial Onset SeizuresSeizuresNCT00697918SK Life Science, Inc.11
已完成
1 期
Vitamin E δ-Tocotrienol Administered to Subjects With Resectable Pancreatic Exocrine NeoplasiaPancreatic NeoplasmsNCT00985777H. Lee Moffitt Cancer Center and Research Institute26